Abbott: FDA approves Proclaim XR spinal cord stimulation system

Abbott announced that the U.S. FDA has approved its Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy, a debilitating complication of diabetes. The Proclaim XR SCS system can provide relief to DPN patients in need of alternatives to traditional treatment approaches, such as oral medication. People who receive therapy from the Proclaim XR SCS system will also be able to use Abbott’s NeuroSphere Virtual Clinic, a connected care app that allows people to communicate with a physician and receive treatment adjustments remotely.